Covered recipient · General Payments record
MATTHEW JOSEPH CORTESE
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2024
$31,553.00
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $20,800.50 | 7 |
| Travel and Lodging | $1,405.62 | 7 |
| Food and Beverage | $413.48 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $14,292.50 | 3 |
| ABBVIE INC. | $4,392.12 | 13 |
| E.R. Squibb & Sons, L.L.C. | $2,768.00 | 1 |
| SECURA BIO, INC. | $990.00 | 1 |
| Genmab U.S., Inc. | $105.35 | 1 |
| Genentech USA, Inc. | $71.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $550.00 | 02/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103133123 | CMS |
| ABBVIE INC. | $487.00 | 07/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104181832 | CMS |
| ABBVIE INC. | $174.90 | 07/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104181834 | CMS |
| ABBVIE INC. | $33.80 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505206 | CMS |
| ABBVIE INC. | $33.80 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505208 | CMS |
| ABBVIE INC. | $584.71 | 07/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104181836 | CMS |
| ABBVIE INC. | $2,200.00 | 10/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103133125 | CMS |
| ABBVIE INC. | $36.46 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505210 | CMS |
| ABBVIE INC. | $41.89 | 10/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104181838 | CMS |
| ABBVIE INC. | $38.99 | 10/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104181840 | CMS |
| ABBVIE INC. | $38.13 | 10/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104181842 | CMS |
| ABBVIE INC. | $40.00 | 10/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104181844 | CMS |
| ABBVIE INC. | $132.44 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103505212 | CMS |
| AstraZeneca Pharmaceuticals LP | $2,397.50 | 07/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105556308 | CMS |
| AstraZeneca Pharmaceuticals LP | $2,055.00 | 08/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104762470 | CMS |
| AstraZeneca Pharmaceuticals LP | $9,840.00 | 10/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104283159 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,768.00 | 03/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101314189 | CMS |
| Genentech USA, Inc. | $71.63 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133065511 | CMS |
| Genmab U.S., Inc. | $105.35 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126829536 | CMS |
| Secura Bio, Inc. | $990.00 | 06/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133336341 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.